Dubai Telegraph - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.315163
AFN 77.725895
ALL 96.43291
AMD 448.42053
ANG 2.103709
AOA 1077.467594
ARS 1690.01099
AUD 1.769939
AWG 2.117923
AZN 1.999871
BAM 1.955453
BBD 2.365881
BDT 143.554559
BGN 1.95541
BHD 0.442997
BIF 3469.97028
BMD 1.174992
BND 1.514425
BOB 8.146556
BRL 6.363054
BSD 1.174692
BTN 106.551719
BWP 15.514251
BYN 3.435291
BYR 23029.838609
BZD 2.362481
CAD 1.618663
CDF 2643.73129
CHF 0.935882
CLF 0.027386
CLP 1074.329983
CNY 8.280461
CNH 8.26857
COP 4486.118562
CRC 587.595865
CUC 1.174992
CUP 31.137282
CVE 110.245462
CZK 24.315047
DJF 209.182928
DKK 7.470568
DOP 74.616776
DZD 152.31646
EGP 55.708242
ERN 17.624876
ETB 182.828499
FJD 2.707475
FKP 0.878183
GBP 0.877084
GEL 3.166581
GGP 0.878183
GHS 13.508606
GIP 0.878183
GMD 86.365323
GNF 10215.146184
GTQ 8.998405
GYD 245.756447
HKD 9.139621
HNL 30.941516
HRK 7.528524
HTG 153.912068
HUF 384.761044
IDR 19600.80139
ILS 3.778544
IMP 0.878183
INR 106.933475
IQD 1538.833833
IRR 49478.903312
ISK 148.201658
JEP 0.878183
JMD 187.726731
JOD 0.833039
JPY 181.960993
KES 151.459077
KGS 102.753241
KHR 4700.14703
KMF 493.496263
KPW 1057.492883
KRW 1734.264361
KWD 0.360251
KYD 0.978931
KZT 605.875204
LAK 25454.488908
LBP 105211.210708
LKR 363.21563
LRD 207.359723
LSL 19.708907
LTL 3.469446
LVL 0.710742
LYD 6.367871
MAD 10.782289
MDL 19.828486
MGA 5236.072054
MKD 61.51478
MMK 2467.207805
MNT 4167.510126
MOP 9.416571
MRU 46.727719
MUR 53.956056
MVR 18.095668
MWK 2036.93901
MXN 21.110492
MYR 4.802778
MZN 75.081179
NAD 19.708991
NGN 1705.817812
NIO 43.232154
NOK 11.95493
NPR 170.460791
NZD 2.030521
OMR 0.451765
PAB 1.174692
PEN 3.955716
PGK 4.992094
PHP 68.957889
PKR 329.203858
PLN 4.222862
PYG 7889.60179
QAR 4.281241
RON 5.09112
RSD 117.375801
RUB 93.235182
RWF 1710.296898
SAR 4.408618
SBD 9.587985
SCR 15.872309
SDG 706.758342
SEK 10.930608
SGD 1.515828
SHP 0.881548
SLE 28.258416
SLL 24638.994138
SOS 670.181229
SRD 45.366098
STD 24319.957253
STN 24.495555
SVC 10.278222
SYP 12993.612358
SZL 19.712507
THB 37.023673
TJS 10.802565
TMT 4.112471
TND 3.435391
TOP 2.829099
TRY 50.189184
TTD 7.972587
TWD 36.962298
TZS 2902.229785
UAH 49.651901
UGX 4184.258458
USD 1.174992
UYU 46.037718
UZS 14211.541879
VES 314.239504
VND 30951.633094
VUV 142.716636
WST 3.26567
XAF 655.840771
XAG 0.018612
XAU 0.000274
XCD 3.175474
XCG 2.117034
XDR 0.815655
XOF 655.840771
XPF 119.331742
YER 280.17686
ZAR 19.744917
ZMK 10576.339012
ZMW 27.223175
ZWL 378.346869
  • SCS

    0.0200

    16.14

    +0.12%

  • CMSC

    0.0000

    23.3

    0%

  • BCC

    -1.1800

    75.33

    -1.57%

  • NGG

    1.1000

    76.03

    +1.45%

  • GSK

    0.4300

    49.24

    +0.87%

  • RIO

    0.1600

    75.82

    +0.21%

  • BTI

    0.6400

    57.74

    +1.11%

  • BCE

    0.2161

    23.61

    +0.92%

  • RBGPF

    0.4300

    81.6

    +0.53%

  • CMSD

    0.1150

    23.365

    +0.49%

  • JRI

    -0.0065

    13.56

    -0.05%

  • RYCEF

    0.3100

    14.95

    +2.07%

  • RELX

    0.7000

    41.08

    +1.7%

  • AZN

    1.7300

    91.56

    +1.89%

  • VOD

    0.1100

    12.7

    +0.87%

  • BP

    -0.0100

    35.25

    -0.03%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

Y.El-Kaaby--DT